Stock 2216 BRONCUS HOLDING CORPORATION
Add to a list
To use this feature you must be a member
Log inSign up

Broncus Holding Corporation Stock

Equities

2216

KYG1609T1022

Advanced Medical Equipment & Technology

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:35 2024-04-19 am EDT 		5-day change 1st Jan Change
0.54 HKD 0.00% Intraday chart for Broncus Holding Corporation -10.00% -31.65%
Mar. 28 Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Mar. 01 Broncus Holding Corporation Announces Resignation of Zhenjun Zi as Non-Executive Director CI

Financials

Sales 2023 10.26M 80.33M Sales 2024 * 13.03M 102M Capitalization 36.35M 285M
Net income 2023 -28M -219M Net income 2024 * - EV / Sales 2023 5.2 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.79 x
P/E ratio 2023
-1.69 x
P/E ratio 2024 *
-
Employees 308
Yield 2023 *
-
Yield 2024 *
-
Free-Float 78.47%
More Fundamentals * Assessed data

Chart Broncus Holding Corporation

Dynamic Chart

Latest news about Broncus Holding Corporation

Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Broncus Holding Corporation Announces Resignation of Zhenjun Zi as Non-Executive Director CI
Broncus Holding Corporation Announces Passing Away of Joseph Wan Yee Lau, an Independent Non-Executive Director and Member of the Audit Committee and Nomination Committee CI
Broncus Arm Terminates License Agreement With NoahTron Intelligence MT
Broncus Unit to Purchase Medical Device Maker MT
Broncus Acquires Fibernova for $2.7 Million MT
Broncus Holding Corporation entered into share purchase agreement to acquire Fibernova Holding Corporation from from Zhao and others for $2.7 million. CI
Broncus Holding Corporation Announces Chief Executive Officer Changes, Effective on September 1, 2023 CI
Broncus Holding Corporation Announces Re-Designation of Guowei Zhan from an Executive Director to Non-Executive Director, Effective September 1, 2023 CI
Broncus Holding Corporation Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Broncus Holding Corporation Completes the First Case of Registered Clinical Trials of Its Targeted Lung Denervation Radiofrequency Ablation System CI
Broncus Completes First Case of Clinical Trials for COPD Treatment MT
Broncus Holding Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Broncus Flags Nearly $12 Million Exposure to Silicon Valley Bank MT
Chinese shares jump on recovery optimism, Fed pause bets RE
More news

Press releases Broncus Holding Corporation

Broncus Medical (02216.HK) Announces Interim Results for 2023 PR
Broncus : Qiming's Portfolio Company Broncus Lists on Main Board of HKEx PR
Broncus : Lists on Main Board of HKEx PR
More press releases

News in other languages on Broncus Holding Corporation

Las acciones chinas suben ante el optimismo en la recuperación y las apuestas a una pausa de la Fed
More news

Quotes and Performance

1 week-10.00%
Current month-5.26%
1 month-14.29%
3 months-27.03%
6 months-44.90%
Current year-31.65%
More quotes

Highs and lows

1 week
0.51
Extreme 0.51
0.58
1 month
0.46
Extreme 0.46
0.63
Current year
0.46
Extreme 0.46
0.80
1 year
0.46
Extreme 0.46
1.92
3 years
0.46
Extreme 0.46
18.00
5 years
0.46
Extreme 0.46
18.00
10 years
0.46
Extreme 0.46
18.00
More quotes

Managers and Directors - Broncus Holding Corporation

Managers TitleAgeSince
Hong Xu CEO
 Chief Executive Officer 38 18-02-21
Guo Wei Zhan BRD
 Director/Board Member 48 17-11-30
Yin Kwan Ho SEC
 Corporate Secretary 47 22-08-29
Members of the board TitleAgeSince
Yi Wei Zhao CHM
 Chairman 58 12-04-29
Guo Wei Zhan BRD
 Director/Board Member 48 17-11-30
Ao Zhang BRD
 Director/Board Member 39 21-04-28
More insiders

Quotes

Date Price Change Volume
24-04-19 0.54 0.00% 0
24-04-18 0.54 +5.88% 25,000
24-04-17 0.51 -10.53% 34,500
24-04-16 0.57 -1.72% 36,000
24-04-15 0.58 -3.33% 0

Delayed Quote Hong Kong S.E., April 19, 2024 at 04:08 am EDT

More quotes

Company Profile

Broncus Holding Corp is a China-based investment holding company providing innovative solutions for lung diseases. The Company's business includes providing diagnostic solutions, lung cancer treatment solutions, chronic obstructive pulmonary disease solutions and navigation platforms. The diagnostic solutions pruducts include FleXNeedle, ATV Sheath, ATV Balloon and others. The lung cancer treatment solutions products include InterVapor for lung cancer, H-Marker and others. The chronic obstructive pulmonary disease (COPD) solutions products include InterVapor for COPD and TLD Ablation System. The navigation platform products include Lungpoint, Lungpro, New Generation Navigation Platform and others.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-08-27 - Q2 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Ratings for Broncus Holding Corporation

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.069 USD
Average target price
0.137 USD
Spread / Average Target
+98.68%
Consensus

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Imaging Systems

1st Jan change Capi.
BRONCUS HOLDING CORPORATION Stock Broncus Holding Corporation
-31.65% 36.35M
SHANGHAI UNITED IMAGING HEALTHCARE CO., LTD. Stock Shanghai United Imaging Healthcare Co., Ltd.
-10.31% 13.99B
IRAY TECHNOLOGY COMPANY LIMITED Stock iRay Technology Company Limited
-40.33% 2.73B
SONOSCAPE MEDICAL CORP. Stock SonoScape Medical Corp.
-20.66% 2.23B
BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Wandong Medical Technology Co.,Ltd.
-15.69% 1.4B
NANO-X IMAGING LTD. Stock Nano-X Imaging Ltd.
+40.20% 524M
GUERBET Stock Guerbet
+70.77% 445M
DETECTION TECHNOLOGY OYJ Stock Detection Technology Oyj
-2.55% 216M
VIEWORKS CO., LTD. Stock Vieworks Co., Ltd.
+1.11% 182M
INTROMEDIC CO., LTD. Stock IntroMedic Co., Ltd.
-.--% 168M
Medical Imaging Systems
  1. Stock Market
  2. Equities
  3. 2216 Stock